Paul Hopper

Paul Hopper

Founder at IMUGENE LIMITED

Net worth: 31 M $ as of 2024-03-30

68 year
Health Technology
Finance
Commercial Services

Profile

Paul A.
Hopper
is the founder of Prescient Therapeutics Ltd.
(founded in 1986) and Imugene Ltd.
(founded in 2012).
He is also the founder of Chimeric Therapeutics Ltd.
(founded in 2020).
Currently, Mr. Hopper holds the position of Chairman at Vaxinia Pty Ltd., Executive Chairman at Radiopharm Theranostics Ltd., Managing Director at Cappello Group, Inc., Director at Biolife Science Ltd., President & Director at Radiopharm Theranostics (USA), Inc., MD, Head-Life Sciences & Biotechnology Group at Cappello Global LLC, and Member at Pacific Council on International Policy.
In his former positions, Mr. Hopper served as Executive Chairman at CAQ Holdings Ltd., Viralytics Pty Ltd., and Botanix Pharmaceuticals Ltd.
He was also the Executive Chairman at Arovella Therapeutics Ltd.
from 2019 to 2022.
Additionally, he held various roles such as Chairman-California Chapter at American Australian Association, Executive Chairman at Bioscience Oncology Pty Ltd., Director at Fibrocell Science, Inc., Director at Advanced Biotherapy, Inc., Independent Non-Executive Director at Somnomed Ltd., Director at Medaire Ltd., Chief Operating Officer & Director at Acuvax Ltd., Independent Director at EyePoint Pharmaceuticals, Inc., Non-Executive Director at Respiri Ltd., Managing Director at Avantogen Ltd., Independent Director at Scopus Biopharma, Inc., and President at Innovate Oncology, Inc. Mr. Hopper's education includes an undergraduate degree from The University of New South Wales.
Mr. Hopper is also the founder of Pathway Oncology Pty Ltd., Glioblast Pty Ltd., Polynoma LLC, and Alpha Healthcare Ltd...

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-31 422,219,760 ( 5.77% ) 29 M $ 2024-03-30
2023-09-20 94,137,432 ( 11.12% ) 2 M $ 2024-03-30
2022-11-24 423,521 ( 0.10% ) 15 471 $ 2024-03-30

Paul Hopper active positions

CompaniesPositionStart
IMUGENE LIMITED Founder 2012-10-30
CHIMERIC THERAPEUTICS LIMITED Founder 2020-02-01
RADIOPHARM THERANOSTICS LIMITED Chairman 2021-02-10
Chairman -
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 2005-10-31
President -
All active positions of Paul Hopper

Former positions of Paul Hopper

CompaniesPositionEnd
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Paul Hopper's experience

Training of Paul Hopper

The University of New South Wales Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Hopper's experience

Connections

100 +

1st degree connections

33

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies10
SOMNOMED LIMITED

Health Technology

CAQ HOLDINGS LIMITED

Finance

PRESCIENT THERAPEUTICS LIMITED

Health Technology

IMUGENE LIMITED

Health Technology

BOTANIX PHARMACEUTICALS LIMITED

Health Technology

EYEPOINT PHARMACEUTICALS, INC.

Health Technology

AROVELLA THERAPEUTICS LIMITED

Health Technology

RESPIRI LIMITED

Health Technology

SCOPUS BIOPHARMA INC.

Health Technology

RADIOPHARM THERANOSTICS LIMITED

Health Services

Private companies22

Health Technology

Finance

Finance

Retail Trade

Health Technology

Health Technology

Finance

Innovate Oncology, Inc.

Health Technology

Commercial Services

Commercial Services

The Merchants Bank of New York

Finance

Health Technology

Avantogen Ltd.

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Chimeric Therapeutics Ltd. (Australia)

C19 Therapeutics Pty Ltd.

Bioscience Oncology Pty Ltd.

Health Technology

See company connections